Vyvanse 59417-0107
Generic: Lisdexamfetamine Dimesylate
Product NDC
59417-0107- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- February 23, 2007
- Listing Expires
- December 31, 2027
- Application
- NDA021977
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lisdexamfetamine Dimesylate | 70 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Packaging Options(1)
100 CAPSULE in 1 BOTTLE (59417-107-10)